Articles tagged "Outcome"

2018 American Transplant Congress
Specialized Transplant Critical Care Model Improves Access to Transplantation and Short-Term Survival Outcomes after Liver Transplantation in the Highest Acuity Patients
M. Selim,¹ M. Zimmerman,¹ J. Kim,¹ T. Pearson,¹ C. Eriksen,¹ M. Wong,¹ B. Boettcher,² K. Regner,³ K. Saeian,⁴ H. Woehlk,² J. Hong.¹
¹Department of Surgery, Division of Transplant Surgery, Medical College of Wisconsin, Milwaukee, WI; ²Department of Anesthesia, Medical College of Wisconsin, Milwaukee, WI; ³Department of Medicine, Division of Nephrology, Medical College of Wisconsin, Milwaukee, WI; ⁴Department of Medicine, Division of Gastroenterology, Medical College of Wisconsin, Milwaukee, WI.
Objective: Liver transplantation (LT) is a lifesaving treatment for end stage liver disease (ESLD). High acuity ESLD patients are disadvantaged as they are frequently denied…
2018 American Transplant Congress
Safety and Tolerability of Therapy for Latent Tuberculosis Infection: A 16-Year Review
Y. AlJishi, M. Bosaeed, S. Husain, C. Rotstein, A. Humar, D. Kumar.
Transplant Infectious Diseases, UHN, Toronto, ON, Canada.
Introduction:Screening and therapy of latent tuberculosis infection (LTBI) is recommended in transplant candidates. However, data on therapy of LTBI with fluoroquinolones are limited. We aimed…
2018 American Transplant Congress
Pre-Existing Allograft Diabetic Nephropathy from Diabetic Donor is Reversible after Kidney Transplantation in Non-Diabetic Recipient
K. Hotta,¹ D. Iwami,¹ H. Harada,² Y. Fukasawa,² H. Okada,¹ H. Higuchi,¹ T. Hirose,² N. Fukuzawa,² N. Shinohara.¹
¹Hokkaido University Hospital, Sapporo, Japan; ²Sapporo City General Hospital, Sapporo, Japan.
【Introduction】The shortage of kidney donor has limited the treatment of patients with end-stage kidney disease. To use diabetic donor with normal renal function is would…
2018 American Transplant Congress
Laparoscopic Donor Nephrectomy Safety: Experience of 500 Cases in Hispanic Population at a Single Institution
Y. Baez Suarez, F. Giron Luque, J. Amaya Nieto.
Transplantation Surgery, Colombiana de Trasplantes, Bogota, Colombia.
Background: Laparoscopic live donor nephrectomy (LDN) has become the best option in living donation because its safety and low rate of complications. This report aims…
2017 American Transplant Congress
Eight Year Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients.
J. Leventhal,¹ J. Galvin,¹ J. Mathew,¹ L. Gallon,¹ D. Stare,¹ A. Sweeney,¹ J. Miller,¹ M. Abecassis,¹ S. Ildstad.²
¹Northwestern University, Chicago; ²U of Louisville, Louisville
36 subjects have been transplanted in a phase 2 protocol (IDE 13947) to induce tolerance in recipients of living donor renal allografts (KTx). The protocol…
2017 American Transplant Congress
The Clinical and Economic Burden of Pneumonia in Canadian Solid Organ Transplant Recipients.
N. Law,¹ B. Hamandi,² A. Alghamdi,¹ E. Papadimitropoulos,² S. Husain.¹
¹Multi Organ Transplant Program, University Health Network, Toronto, ON, Canada; ²Department of Pharmacy, University Health Network, Toronto, ON, Canada
Introduction:Due to the limited amount of health resources available, there is a need for health program and economic evaluation to inform stakeholders about optimum resource…
2017 American Transplant Congress
Donor Recipient Matching Based on HLA Epitopes Improves Outcome in Kidney Transplant Recipients.
O. Staeck,¹ M. Niemann,³ F. Halleck,¹ D. Khadzhynov,¹ C. Schönemann,² P. Reinke,¹ E. Spierings,⁴ K. Budde,¹ N. Lachmann.²
¹Nephrology, Charité Universitaetsmedizin, Berlin, Germany; ²HLA Laboratory, Charité Universitaetsmedizin, Berlin, Germany; ³PIRCHE, Berlin, Germany; ⁴Laboratory of Translational Immunology, UMC Utrecht, Utrecht, Netherlands
Background: HLA mismatches of the donor and recipient causing de novo donor-specific HLA antibodies (dnDSA) are a risk factor for immunologic complications and poor graft…
2017 American Transplant Congress
Donor Factors Show Low Impact on Patient and Kidney Allograft Outcomes: A Paired Analysis of Left/Right Deceased Donor Kidney Pairs.
T. Schachtner,^1,2,3 M. Stein,² P. Reinke.^1,2
¹Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany; ²Berlin-Brandenburg Center for Regenerative Therapies, Charite Campus Virchow Clinic, Berlin, Germany; ³Charite and Max-Delbrück Center, Berlin Institute of Health BIH, Berlin, Germany
The impact of donor factors on kidney allograft outcomes and infectious complications has been suggested in many previous studies. However, analyses of left/right donor kidney…
2017 American Transplant Congress
A2 Incompatible Kidney Transplantation: A Single Center Experience.
L. Kamal, M. Ajaimy, M. Lubetzky, G. DeBoccardo, P. Bedi, S. Greenstein, J. Rocca, J. Graham, M. Kinkhabwala, A. Chokechanachaisakul, A. Courson, E. Akalin.
Montefiore Medical Center Transplant Center, Albert Einstein College of Medicine, NY
Background: The new kidney allocation system implemented in December 2014 allowed for use of A2/A2B donors to B recipients. However there is no mandate by…
2017 American Transplant Congress
Donor Smoking History Associated with Increased Risk of Death Following Lung Transplantation, but Lower Risk of Bronchiolitis Obliterans Syndrome.
S. Burger, M. Eberlein, J. Keech, E. Arshava, T. Pena, S. Larson, J. Klesney-Tait, K. Parekh.
Cardiothoracic Surgery, University of Iowa, Iowa City, IA
Purpose: The impact of donor smoking history on long term mortality, causes of mortality and the development of bronchiolitis obliterans syndrome (BOS) following lung transplantation…